DW was interviewed this morning by John Hester, Bell Potter (Healthcare Analyst) at the Bell Potter Heathcare conference. No slides or significant information, apart from one. John took David head on about the lack of update or guidance at the recent AGM.

David explained that the Board is comfortable with analyst consensus, and if they weren't - either up or down - they would update the market. At the same time, he said they will not give forward guidance because, with their high growth, doing that is a pathway to trouble (I agree!)

So, the best view is that $PNV is on track to achieve about 28% revenue growth in FY25, with consensus at $134.5m. (My source: www. marketscreener.com. n= 9)

Disc: Held in RL and SM